Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urushiol is a mixture of oily organic compounds, specifically alkyl-substituted catechols, found in plants of the genus Toxicodendron, such as poison ivy, poison oak, and poison sumac (PubChem). It is not a therapeutic target but rather a potent exogenous allergen that triggers urushiol-induced contact dermatitis, a form of Type IV delayed-type hypersensitivity (StatPearls). Upon skin contact, the lipophilic urushiol molecules penetrate the epidermis and undergo oxidation to form reactive quinones, which then covalently bind to skin proteins (Wikipedia). This process, known as haptenization, creates an antigenic complex that is recognized by T-lymphocytes, leading to an inflammatory cascade characterized by intense itching, redness, and blistering (PubMed, PMID: 30554565). While urushiol itself is not targeted by drugs for inhibition, therapeutic intervention focuses on mitigating the resulting immune response using corticosteroids and antihistamines (Mayo Clinic). Prevention involves the use of barrier creams like bentoquatam or specialized cleansers to remove the oil before it binds to the skin (StatPearls).
Urushiol acts as a hapten that penetrates the skin and binds to membrane proteins on antigen-presenting cells, triggering a T-cell mediated (Type IV) hypersensitivity reaction (StatPearls). Therapeutic agents do not typically target the urushiol molecule itself for inhibition; instead, they suppress the resulting immune response or facilitate the physical removal of the oil from the skin surface.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urushiol.